GIP/GLP-1 dual receptor agonist
Tirzepatide in France: prescription, brands, pricing
This page summarises the situation of Tirzepatide in France under ANSM (Agence nationale de sécurité du médicament et des produits de santé): prescription status, available brands and generics, pharmacy dispensing, and online options in EUR. Tirzepatide belongs to the GIP/GLP-1 dual receptor agonist class.
- Regulator
- ANSM (Agence nationale de sécurité du médicament et des produits de santé)
- Currency
- EUR
About Tirzepatide
Tirzepatide is approved in adults with type 2 diabetes mellitus, as monotherapy or in combination with other antidiabetic agents, to improve glycaemic control. In France, prescription medications are tightly regulated under several lists (Liste I, Liste II, stupéfiants). Sécurité sociale covers most prescription costs at varying rates depending on the drug.
Mechanism and action
Tirzepatide binds with high affinity to the GIP receptor and to the GLP-1 receptor.
Brands and generics in France
In France, Tirzepatide is typically dispensed as one internationally recognised brand along with their corresponding authorised generics. Pharmacies in France are independent owner-pharmacist businesses, marked by the iconic green cross. The pharmacist is a routine medical consultant for minor ailments and triage. Brand-to-generic substitution is decided by the pharmacist under local ANSM (Agence nationale de sécurité du médicament et des produits de santé) equivalence rules, and the price difference in EUR is usually substantial.
Online and tele-prescribing access
Online pharmacy is permitted only via French ARS-authorised pharmacies physically located in France, primarily for non-prescription medication. Tele-consultation has expanded prescription access since 2020. For Tirzepatide specifically, the legal online options in France depend on its Rx-or-OTC classification under ANSM (Agence nationale de sécurité du médicament et des produits de santé).
Frequently asked questions
Is Tirzepatide available in France? ▾
Yes — Tirzepatide and its brands are available in France through pharmacies authorised by ANSM (Agence nationale de sécurité du médicament et des produits de santé), in various strengths depending on the commercial product. Authorised generics offer a lower-cost alternative with the same active substance.
Do I need a prescription for Tirzepatide in France? ▾
In France, prescription medications are tightly regulated under several lists (Liste I, Liste II, stupéfiants). Sécurité sociale covers most prescription costs at varying rates depending on the drug. The exact status of Tirzepatide (Rx or OTC) is determined by ANSM (Agence nationale de sécurité du médicament et des produits de santé); most active ingredients in the GIP/GLP-1 dual receptor agonist class require prescription, although there are exceptions by country and formulation.
How much does Tirzepatide cost in France? ▾
The price in EUR depends on the manufacturer (brand vs authorised generic), the strength and the pack size. Generics are typically substantially cheaper than brands and serve as the economic reference for ongoing use.
Products with Tirzepatide in France
Tirzepatide in other countries
The information on this website is provided for reference and educational purposes only. It does not replace consultation with a qualified healthcare professional.